Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The protein p27(Kip1) regulates cell cycle progression in mammals by inhibiting the activity of cyclin-dependent kinases (CDKs). Here we show that p27(Kip1) progressively accumulates in the nucleus of pancreatic beta cells in mice that lack either insulin receptor substrate 2 (Irs2(-/-)) or the long form of the leptin receptor (Lepr(-/-) or db/db). Deletion of the gene encoding p27(Kip1) (Cdkn1b) ameliorated hyperglycemia in these animal models of type 2 diabetes mellitus by increasing islet mass and maintaining compensatory hyperinsulinemia, effects that were attributable predominantly to stimulation of pancreatic beta-cell proliferation. Thus, p27(Kip1) contributes to beta-cell failure during the development of type 2 diabetes in Irs2(-/-) and Lepr(-/-) mice and represents a potential new target for the treatment of this condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cell cycle inhibitor p27, a marker of senescence, increases in pancreatic β-cells in genetic mouse models of type 2 diabetes, and p27 deletion in those mice increased insulin secretion and islet mass through increased proliferation (64).”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [64]
In the citing paper
“For instance, when cell cycle arrest is induced specifically in β-cells by overexpression of p27 [24] or by deletion of Cdk4 postnatally, β-cell mass decreases or fails to expand, which would not be the case if neogenesis or transdifferentiation were major sources of new β-cells [25,26].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [24]
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594 · cited 1×
“This effect of Akt is mediated by the transcriptional regulator Foxo1 (refs”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · cited 1×
“The mass of pancreatic islets is also reduced in individuals with this conditio”
BackgroundA mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Abnormal splicing of the leptin receptor in diabetic mice
Lee, G.-H., Proenca, R., Montez, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., & Friedman, J. M. (1996) · Nature · doi:10.1038/379632a0 · Cited by 2,327 · cited 1×
“These mice develop obesity because of hyperphagia, decreased energy expenditure and preferential partitioning of calories into adipose tissue triglyceride”
BackgroundChen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., More, K. J., Breitbart, R. E., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81294-5 · Cited by 2,214
Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., & Rolfe, M. (1995) · Science · doi:10.1126/science.7624798 · Cited by 1,817 · cited 1×
“, resulting in its degradation by the ubiquitin-proteasome pathwa”
BackgroundDisruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775 · cited 1×
“Irs2-deficient ( Irs2 −/− ) mice do not maintain islet mass in the face of hepatic insulin resistanc”
BackgroundSelf-citationNakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Self-citation
Cited by
Mahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
p16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
Thrailkill, K. M., Lumpkin, C. K., Bunn, R. C., Kemp, S. F., & Fowlkes, J. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00159.2005 · Cited by 490
“How insulin signaling might promote osteoblastogenesis is speculative; however, studies examining pancreatic -cells suggests a direct action of insulin to inactivate p27, a cyclin-dependent kinase inhibitor that could attenuate cell proliferation in osteoblasts (128).”
BackgroundAge-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk
Chia, C. W., Egan, J. M., & Ferrucci, L. (2018) · Circulation Research · doi:10.1161/circresaha.118.312806 · Cited by 454
“Deletion of p27 seemed to enhance insulin secretion because of increased number of β-cell proliferation.(136) However, a recent study showed that in healthy old mice and healthy humans, p16-induced senescence of β cells resulted in enhanced insulin secretion compared with β cells from young animals in response to high…”
ResultRETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation
Yi, P., Park, J.-S., & Melton, D. A. (2013) · Cell · doi:10.1016/j.cell.2013.04.008 · Cited by 449
“On the contrary, cell-cycle inhibitors, including p15 Ink4b , p18 Ink4c , and p27 Kip1 , repress b cell replication (Latres et al., 2000; Pei et al., 2004; Uchida et al., 2005).”
BackgroundRetracted
Metadata
- Authors
- Uchida, T., Nakamura, T., Hashimoto, N., Matsuda, T., Kotani, K., Sakaue, H., Kido, Y., Hayashi, Y., Nakayama, K. I., White, M. F., & Kasuga, M.
- Affiliations
- Kobe University (JP)
- Kyushu University (JP)
- Joslin Diabetes Center (US)
- Corresponding author
- Kasuga, Masato
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-01-30
- Volume
- 11
- Issue
- 2
- Pages
- 175-182
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2151058113
- Cited by
- 218
- References
- 48
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 4 · 2019: 4 · 2018: 9 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 8 · 2013: 9 · 2012: 13
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- p27, type 2 diabetes, hyperglycemia, compensatory hyperinsulinemia, pancreatic beta cells, beta-cell proliferation, beta-cell failure, insulin receptor substrate 2, leptin receptor, db/db mice, islet mass, cyclin-dependent kinase inhibition
- MeSH terms
- Animals, Cell Nucleus, Diabetes Mellitus, Type 2, Disease Models, Animal, Enzyme Inhibitors, Hyperglycemia, Hyperinsulinism, Insulin-Like Growth Factor I, Islets of Langerhans, Phosphoproteins, Proto-Oncogene Proteins, Receptors, Cell Surface, Signal Transduction, Protein Serine-Threonine Kinases, Mice, Knockout, Cell Cycle Proteins, Leptin, Tumor Suppressor Proteins, Intracellular Signaling Peptides and Proteins, Cyclin-Dependent Kinase Inhibitor p27, Proto-Oncogene Proteins c-akt, Mice, Receptors, Leptin, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.